BOSTON SCIENTIFIC CORP — Director's Dealing 2021

Feb 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-02-17

Reporting Person: Mirviss Jeffrey B. (EVP&Pres, Periph Intervent)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-18	Common Stock	M	2816.0000	$0.0000	Acquired	135817.0000	Direct
2021-02-18	Common Stock	F	862.0000	$37.5200	Disposed	134955.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-17	Restricted Stock Units	$	A	13333.0000	Acquired	2025-02-17	Common Stock (13333.0000)	Direct
2021-02-17	Stock Option (Right to Buy)	$37.5000	A	42881.0000	Acquired	2031-02-17	Common Stock (42881.0000)	Direct
2021-02-18	Deferred Stock Units	$	M	2816.0000	Disposed	2024-02-18	Common Stock (2816.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F3: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.

F4: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.

F5: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.